MRC1 and Alzheimer disease: In moderate AD, iNOS and IL-1β mRNA levels were increased while CD206 and Arg1 mRNA levels were reduced in both the PtA and Ent in the AD group compared with the WT group (P < 0.01, Figures 9(a)–9(d)).